Regenxbio Inc. (RGNX) PT Raised to $82 at Barclays
Tweet
Share
E-mailGet Alerts RGNX Hot Sheet
Price: $15.90 +1.66%
Rating Summary:
14 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
14 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Barclays analyst Gena Wang raised the price target on Regenxbio Inc. (NASDAQ: RGNX) to $82.00 (from $79.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Fiserv (FI) PT Raised to $175 at TD Cowen
- Boston Beer Company (SAM) PT Lowered to $325 at Jefferies
- JPMorgan Upgrades Samsung SDS Co Ltd (018260:KS) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
